All-carbon-based cathode for a true high-energy-density Li-O₂ battery

Lim, Hee-Dae,Yun, Young Soo,Cho, Se Youn,Park, Kyu-Young,Song, Min Yeong,Jin, Hyoung-Joon,Kang, Kisuk Elsevier 2017 Carbon Vol.114 No.-

<P>Li-O-2 batteries have a high theoretical energy density; however, their current cathode system based on a heavy metal framework strikingly diminishes their real energy density. Herein, we report the fabrication of all-carbon-based cathodes composed of conventional active carbon and a carbon mesh (CM) framework produced from waste silk fabric by simple pyrolysis. CM frameworks show a high electrical conductivity of similar to 150 S cm(-1), good tensile strength of 34.1 +/- 5.2 MPa, and a Young's modulus of 4.03 +/- 0.7 GPa, as well as a well-ventilated ordered macroporous structure. These all-carbon-based cathodes exhibit stable cycling and high energy densities of similar to 2600 Wh kg(-1) based on total electrode weight, which are 4-15 times higher than those of conventional air cathodes. (C) 2016 Elsevier Ltd. All rights reserved.</P>

Poly(vinyl alcohol) nanocomposites containing reduced graphene oxide coated with tannic acid for humidity sensor

Lim, Min-Young,Shin, Huiseob,Shin, Dong Myung,Lee, Sang-Soo,Lee, Jong-Chan Elsevier 2016 Polymer Vol.84 No.-

<P><B>Abstract</B></P> <P>Poly(vinyl alcohol) (PVA) nanocomposites were prepared by a solution casting method using a reduced graphene oxide coated with tannic acid (rGO-TA) as a filler. The rGO-TA was simply prepared by mixing tannic acid (TA) with graphene oxide (GO). The simple mixing process was found to be effective to reduce GO and to produce covalently-grafted TA layers on the reduced GO. The mechanical properties of PVA were much improved by the addition of rGO-TA because the TA layers increased the compatibility of the reduced GO with PVA matrix. For example, Young's modulus and elongation at break values of PVA were increased by 34.0 and 56.9%, respectively, by adding 1.0 wt% of rGO-TA. In addition, the PVA nanocomposites showed excellent humidity sensing properties over the wide relative humidity range and the long-term stability due to the conductive property of the reduced GO and the enhanced mechanical strength by the effective incorporation of rGO-TA into the PVA matrix.</P> <P><B>Highlights</B></P> <P> <UL> <LI> The rGO-TA was prepared by a facile and green method using a low-cost tannic acid. </LI> <LI> The effect of rGO-TA on the properties of PVA nanocomposites has been studied. </LI> <LI> The rGO-TA improved the important properties for PVA-based humidity sensors. </LI> <LI> The PVA/rGO-TAs are promising materials for high-performance humidity sensors. </LI> </UL> </P> <P><B>Graphical abstract</B></P> <P>[DISPLAY OMISSION]</P>

정신분열병에 대한 리스페리돈의 효과 및 안정성

이민수,김용구,김영훈,연병길,오병훈,윤도준,윤진상,이철,정희연,강병조,김광수,김동언,김명정,김상훈,김희철,나철,노승호,민경준,박기창,박두병,백기청,백인호,손봉기,손진욱,양병환,양창국,우행원,이정호,이종범,이홍식,임기영,전태연,정영조,정영철,정인과,정인원,지익성,채정호,한상익,한선호,한진희,서광윤 大韓神經精神醫學會 1998 신경정신의학 Vol.37 No.1

연구목적 : 본 시험의 목적은 임상시험 시작전에 연구자들을 대상으로 PANSS Workshop을 통하여 PANSS, ESRS에 대한 국내에서의 표준화 작업을 구축하고 새로운 정신병 치료제인 리스페리돈의 효과와 안정성을 재확인하여 리스페리돈 사용에 대한 적정화를 이루는데 있다. 연구방법 : 1996년 4월부터 1996년 9월까지 국내 39개 대학병원 정신과에 입원중인 혹은 증상이 악화되어 입원하는 정신분열병 환자 377명을 대상으로 다시설 개방 연구를 시행하였다. 1주일간의 약물 배설기간을 가진후, 리스페리돈을 8주간 투여하였고, 기준점, 1주, 2주, 4주, 그리고 8주후에 평가되었다. 용량은 제1일에는 리스페리돈 1mg씩 1일 2회, 제2일에는 2mg씩 1일 2회, 제3∼7일에는 3mg씩 1일 2회 투여하였다. 이후 환자의 임상상태에 따라 임의로 증량할 수 있으며, 최대 일일 16mg을 초과하지 않도록 하였다. 추체외로 증상을 조절하기 위한 투약을 허용하였다. 임상증상 및 부작용의 평가는 PANSS(Positive and Negative Syndrome Scale), CGI(Clinical Global Impression) 그리고 ESRS(Extrapyramidal Symptom Rating Scale)을 사용하였다. 연구결과 : 377명중 343명(91%)이 8주간의 연구를 완결하였다. 치료 종결시점인 8주후 PANSS 총점수가 20% 이상 호전된 경우를 약물 반응군으로 정의할때, 약물반응군은 81.3%였다. 리스페리돈에 반응하는 예측인자로는 발병연령, 이전의 입원 횟수, 유병기간이 관련 있었다. 리스페리돈은 1주후부터 PANSS양성, 음성, 및 일반정신병리 점수상에 유의한 호전을 보여 효과가 빨랐다. CGI의 경우도 기준점에 비해 1주후부터 유의한 감소를 나타내었다. ESRS의 경우, 파킨슨 평가점수는 기준점과 비교해 투여 1주, 2주, 4주후 유의하게 증가되었다가 8주후 기준점과 차이가 없었다. Dystonia 평가점수는 1주후만 유의한 증가를 보였으며, dyskinesia 평가점수는 유의한 차이가 없었다. 혈압, 맥박수의 생명징후 및 일반 혈액학 검사, 생화학적 검사, 심전도 검사에서 유의한 변화는 없었다. 결 론 : 이상의 다시설 개방 임상 연구를 통해 리스페리돈은 정신분열병 환자에서 양성증상뿐만 아니라 음성증상 및 전반적인 증상에도 효과적인 것으로 사료된다. 보다 명확한 평가를 위해서는 다른 항정신병약물과의 이중맹검 연구가 필요할 것으로 생각되며, 또한 장기적 치료에 대한 평가도 함께 이루어져야 하겠다. Objective : The purpose of this study was to investigate the efficacy and safety of risperidone in the treatment of Korean schizophrenic patients. Method : This multicenter open study included 377 schizophrenic patients drawn from 39 university hospitals. After a wash-out period of 1 week, the schizophrenic patients were treated with risperidone for 8 weeks and evaluated at 5 points ; at baseline, and 1, 2, 4 and 8 weeks of treatment. The dose was increased from 2mg/day(1mg twice daily) to 6mg/day(3mg twice daily) during the first week and adjusted to a maximum of 16mg/day over the next 7 weeks according to the patient's clinical response. Medication to control extrapyramidal symptoms was permitted. The psychiatric and neurological status of the patients was assessed by PANSS, CGI, and ESRS scales. Results : 343(91%) of 377 patients completed the 8-week trial period. Clinical improvement, as defined by a 20% or more reduction in total PANSS score at end point, was shown by 81.3% of patients. The predictors of response to risperidone were associated older age, shorter duration of illness, fewer previous hospitalization. Risperidone had rapid onset of action ; a significant decrease of the total PANSS and three PANSS factor(positive, negative, general), and CGI was already noticed at the end of first week. For the ESRS, parkinsonism rating scores were significantly increased until week 4 comparing with baseline. Dystonia rating scores were significantly increased until week 1, and dyskinesia rating scores were not significantly changed during the study. Laboratory parameters including vital sign, EKG, hematological, and biochemical values showed no significant changes during the trial. Conclusions : This study suggests that risperidone is generally safe and effective against both the positive and negative symptoms in our group of patients.

성인에서 기관내삽관을 위한 Pipecuronium 일회 정주 적정 용량

최영석,윤석민,임상호,이미경,박영철,류태간 대한마취과학회 1997 Korean Journal of Anesthesiology Vol.33 No.3

Background : Studies in animals suggest that pipecuronium dose not induce hemodynamic chan-ges related to histamine release or to an effect on the autonomic nervous system. Therefore the effects of bolus administration of large doses of pipecuronium, up to 0.20 mg/kg, on the intubation condition, onset and duration of neuromuscular blockade, heart rate and blood pressure were studied during fentanyl- nitrous oxide anesthesia. Method : Forty adults were randomly assigned to receive a bolus injection of either 0.05, 0.10, 0.15, 0.20 mg/kg of pipecuronium. Neuromuscular blockade was measured using mechanomyographic activity of the adductor pollicis muscle after supramaximal stimulation of the ulnar nerve. Four subgroups of 10 patients received pipecuronium doses of 0.05, 0.10, 0.15 and 0.20 mg/kg, respectively, as an intubating dose. Results : The times of onset and clinical duration(mean sem) after each dose were as follows: 0.05 mg/kg, 2.98 0.42 and 41.5 2.42 min; 0.10 mg/kg, 1.54 0.06 and 82.9 7.48 min; 0.15 mg/kg, 1.41 0.14 and 124.8 13.1 min; 0.20 mg/kg, 1.12 0.05 and 187.1 12.8 min. The intubation condition, time of onset and duration after doses of 0.05 mg/kg were significantly different from values after the higer doses. The duration was increased with dose-increments. No dose-related changes in heart rate or blood pressure were observed. Conclusion : The authors conclude that dose of 0.10 mg/kg and over has good intubation condition clinically and large bolus dose of pipecuronium can be safely used with a significantly prolonged duration of action without hemodynamic change. (Korean J Anesthesiol 1997; 33: 453∼457)

Comparing hemostatic resuscitation management of intraoperative massive bleeding with traumatic massive bleeding: a computer simulation

Lee Young Sun,Kim Kyu Nam,Lee Min Kyu,Sun Jung Eun,Hyun Jin Lim,전종헌 대한마취통증의학회 2020 Anesthesia and pain medicine Vol.15 No.4

Background: Appropriate blood component transfusion might differ between intraoperative massive bleeding and traumatic massive bleeding in the emergency department because trauma patients initially bleed undiluted blood and replacement typically lags behind blood loss. We compared these two blood loss scenarios, intraoperative and traumatic, using a computer simulation. Methods: We modified the multi-compartment dynamic model developed by Hirshberg and implemented it using STELLA 9.0. In this model, blood pressure changes as blood volume fluctuates as bleeding rate and transcapillary refill rate are controlled by blood pressure. Using this simulation, we compared the intraoperative bleeding scenario with the traumatic bleeding scenario. In both scenarios, patients started to bleed at a rate of 50 ml/min. In the intraoperative bleeding scenario, fluid was administered to maintain isovolemic status; however, in the traumatic bleeding scenario, no fluid was supplied for up to 30 min and no blood was supplied for up to 50 min. Each unit of packed red blood cells (PRBC) was given when the hematocrit decreased to 27%, fresh frozen plasma (FFP) was transfused when plasma was diluted to 30%, and platelet concentrate (PC) was transfused when platelet count became 50,000/ml. Results: In both scenarios, the appropriate ratio of PRBC:FFP was 1:0.47 before PC transfusion, and the ratio of PRBC:FFP:platelets was 1:0.35:0.39 after initiation of PC transfusion. Conclusion: The ratio of transfused blood component did not differ between the intraoperative bleeding and traumatic bleeding scenarios.

Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 <i>in vitro</i>: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism

Shon, Ji-Hong,Yoon, Young-Ran,Kim, Min-Jung,Kim, Kyoung-Ah,Lim, Young-Chae,Liu, Kwang-Hyeon,Shin, Dong-Hoon,Lee, Chung Han,Cha, In-June,Shin, Jae-Gook Blackwell Science Ltd 2005 British journal of clinical pharmacology Vol.59 No.5

<P>Aims</P><P>We evaluated the involvement of cytochrome P450 (CYP) isoforms 2C9 and 2C19 in chlorpropamide 2-hydroxylation <I>in vitro</I> and in chlorpropamide disposition <I>in vivo</I>.</P><P>Methods</P><P>To identify CYP isoforms(s) that catalyse 2-hydroxylation of chlorpropamide, the incubation studies were conducted using human liver microsomes and recombinant CYP isoforms. To evaluate whether genetic polymorphisms of CYP2C9 and/or CYP2C19 influence the disposition of chlorpropamide, a single oral dose of 250 mg chlorpropamide was administered to 21 healthy subjects pregenotyped for CYP2C9 and CYP2C19.</P><P>Results</P><P>In human liver microsomal incubation studies, the formation of 2-hydroxychlorpropamide (2-OH-chlorpropamide), a major chlorpropamide metabolite in human, has been best described by a one-enzyme model with estimated <I>K</I><SUB><I>m</I></SUB> and <I>V</I><SUB>max</SUB> of 121.7 ± 19.9 µ<SMALL>M</SMALL> and 16.1 ± 5.0 pmol min<SUP>−1</SUP> mg<SUP>−1</SUP> protein, respectively. In incubation studies using human recombinant CYP isoforms, however, 2-OH-chlorpropamide was formed by both CYP2C9 and CYP2C19 with similar intrinsic clearances (CYP2C9 <I>vs.</I> CYP2C19: 0.26 <I>vs.</I> 0.22 µl min<SUP>−1</SUP> nmol<SUP>−1</SUP> protein). Formation of 2-OH-chlorpropamide in human liver microsomes was significantly inhibited by sulfaphenazole, but not by <I>S</I>-mephenytoin, ketoconazole, quinidine, or furafylline. In <I>in vivo</I> clinical trials, eight subjects with the <I>CYP2C9</I>*<I>1/</I>*<I>3</I> genotype exhibited significantly lower nonrenal clearance [*<I>1/</I>*<I>3 vs.</I>*<I>1/</I>*<I>1</I>: 1.8 ± 0.2 <I>vs.</I> 2.4 ± 0.1 ml h<SUP>−1</SUP> kg<SUP>−1</SUP>, <I>P</I> < 0.05; 95% confidence interval (CI) on the difference 0.2, 1.0] and higher metabolic ratios (of chlorpropamide/2-OH-chlorpropamide in urine: *<I>1/</I>*<I>3 vs.</I>*<I>1/</I>*<I>1</I>: 1.01 ± 0.19 <I>vs.</I> 0.56 ± 0.08, <I>P</I> < 0.05; 95% CI on the difference − 0.9, − 0.1) than did 13 subjects with <I>CYP2C9</I>*<I>1/</I>*<I>1</I> genotype. In contrast, no differences in chlorpropamide pharmacokinetics were observed for subjects with the <I>CYP2C19</I> extensive metabolizer <I>vs.</I> poor metabolizer genotypes.</P><P>Conclusions</P><P>These results suggest that chlorpropamide disposition is principally determined by CYP2C9 activity <I>in vivo</I>, although both CYP2C9 and CYP2C19 have a catalysing activity of chlorpropamide 2-hydroxylation pathway.</P>

반응표면분석법을 이용한 대추잎 항산화물질의 에탄올추출조건 최적화

민들레(Dul-Lae Min),임석원(Seokwon Lim),안준배(Jun-Bae Ahn),최영진(Young Jin Choi) 한국식품과학회 2010 한국식품과학회지 Vol.42 No.6

대추잎 항산화 물질의 고효율 추출을 위한 에탄올 용매추출조건을 반응표면분석법을 사용하여 최적화하였다. Box-Behnken design에 따라 추출공정 조작변수(온도, 시간, 에탄올 농도)를 독립변수로, 이에 따라 영향을 받는 종속변수(총 폴리페놀 함량, 총 플라보노이드 함량, 전자공여능)를 설정하여 실험하였다. 추출물의 총 폴리페놀 함량과 총 플라보노이드 함량은 시간과 온도의 영향을 거의 받지 않으며, 용매비가 높을수록 증가하다가 최고점을 보인 후 다시 감소하는 경향을 나타내었다. 전자공여능 또한 시간과 온도의 영향보다는 용매비에 영향을 많이 받는데, 에탄올 농도가 높을수록 전자공여능이 높게 측정되었다. 추출물의 특성을 모두 만족시키는 최적 추출조건 범위 내에서 임의의 조작조건(온도 45℃, 시간 15분, 에탄올 농도 45%)을 설정하였다. 최적조건에서 예측값과 실험값을 비교한 결과, 유사한 값을 보여주어 회귀식이 신뢰할 수 있음을 알 수 있었다. The leaves of Zizyphus jujuba have been used for various purposes including medicine and nutrition. In this study, the conditions for the ethanol extraction of antioxidant from Zizyphus jujuba were optimized using response surface methodology (RSM). A Box-Behnken design containing 15 experimental runs with three replicates was employed to study the effects of solvent extraction conditions such as extraction temperature (℃, X<SUB>1</SUB>), extraction time (min, X<SUB>2</SUB>), and ethanol concentration (%, X<SUB>3</SUB>) on the extraction yield of antioxidants from Zizyphus jujuba. The yields of total polyphenols and total flavonoid, and electron donating activity (EDA) were considered as response variables. The second-order polynomial model gave a satisfactory description of the experimental results showing different patterns of extraction conditions with variation in the linear, quadratic, and interaction effects of the independent variables. Based on four-dimensional RSM, one of the optimized sets of conditions was 45% ethanol, 45℃, and an extraction time of 15 min. Under the optimal conditions, the predicted values were 177.64 mg/g dry basis, 35.99 mg/g dry basis, and 86.14% Vit.C equivalents for total polyphenols, total flavonoids, and EDA, respectively. The experimental values showed good agreements with the predicted values.

오존 처리에 의해 산소 작용기가 도입된 활성탄소의 세슘 흡착 특성

채은선 ( Eunseon Chae ),민충기 ( Chung Gi Min ),임채훈 ( Chaehun Lim ),이영석 ( Young-seak Lee ) 한국공업화학회 2024 공업화학 Vol.35 No.1

세슘은 높은 수용성으로 인하여 인체에 쉽게 침투하여 암 또는 DNA의 변형을 유발하는 잠재적인 독성 오염물질이다. 본 연구에서는 활성탄소의 세슘 흡착 능력을 향상시키고자 오존 처리를 통하여 활성탄소 표면에 산소 작용기를 도입하였다. 오존 처리 시간의 증가에 따라 활성탄소 표면의 산소함량이 증가하였다. 이후 활성탄소와 세슘 사이의 정전기적 상호작용이 더욱 원활하게 이루어져 모든 시료의 세슘 이온 흡착 효율이 향상되었다. 특히 반응기 내부 오존 농도를 50000 ppm으로 하여 7 min 동안 오존 처리한 시료는 약 12%의 높은 산소 작용기 함량을 보이며 97.6%의 가장 높은 세슘 제거 효율을 보였다. 한편, 5 min 동안 처리된 시료는 7 min간 반응한 시료와 비교하여 0.3%의 근소한 세슘 제거율 차이를 보였으며, 이는 오존 기체의 반응 특성으로 인한 두 시료의 표면화학적 유사성에 기인한다. 그러나, 오존 처리된 활성탄소의 세슘 흡착 성능은 활성탄소의 비표면적 및 기공 구조도 중요하지만 표면에 도입된 산소 작용기 양이 주된 영향을 미치는 것으로 판단된다. Cesium is a potential toxic contaminant due to its high solubility, which allows it to easily penetrate the human body and potentially induce cancer or DNA mutations. In this study, oxygen functional groups were introduced on activated carbons (ACs) by ozone treatment to enhance the cesium adsorption capacity. As the ozone treatment time increased, the oxygen content on the ACs surface increased. Subsequently, the electrostatic interaction between ACs and cesium enhanced, resulting in higher cesium ion adsorption efficiency across all samples. In particular, the sample treated with ozone for 7 minutes at an internal ozone concentration of 50000 ppm had roughly 12% greater oxygen functional group content and the highest cesium removal effectiveness (97.6%). Meanwhile, samples treated for 5 minutes showed a 0.3% cesium removal rate difference compared to those treated for 7 minutes, which was caused by the surface chemical similarity of the two samples due to the reactive characteristics of ozone gas. However, the cesium adsorption performance of ozonated activated carbon seems to be mainly influenced by the amount of oxygen functional groups introduced to the surface, although the specific surface area and pore structure of the activated carbon are also important.

Korean physician prescription patterns for home oxygen therapy in chronic obstructive pulmonary disease patients

( Youlim Kim ),( Hwan Il Kim ),( Ji Young Park ),( Ji Young Hong ),( Joo-hee Kim ),( Kyung Hoon Min ),( Chin Kook Rhee ),( Sunghoon Park ),( Chang Youl Lee ),( Seong Yong Lim ),( Seung Hun Jang ),( Yo 대한내과학회 2022 The Korean Journal of Internal Medicine Vol.37 No.1

Background/Aims: Hypoxemia in chronic obstructive pulmonary disease (COPD) leads to reduced ability to exercise, decreased quality of life, and, eventually, increased mortality. Home oxygen therapy in patients with severe COPD reduces distress symptoms and mortality rates. However, there have been few studies on physicians’ prescription behavior toward home oxygen therapy. Therefore, we investigated the respiratory specialists’ perspective on home oxygen therapy. Methods: In this cross-sectional, study, a questionnaire was completed by 30 pulmonary specialists who worked in tertiary hospitals and prescribed home oxygen therapy. The questionnaire consisted of 28 items, including 15 items on oxygen prescription for outpatients, four for inpatients, and nine on service improvement. Results: All physicians were prescribing less than 2 L/min of oxygen for either 24 (n = 10, 33.3%) or 15 hours (n = 9, 30.3%). All (n = 30) used pulse oximetry, 26 (86.7%) analyzed arterial blood gas. Thirteen physicians had imposed restrictions and recommended oxygen use only during exercise or sleep. Sixteen (53.3%) physicians were educating their patients about home oxygen therapy. Furthermore, physicians prescribed home oxygen to patients that did not fit the typical criteria for long-term oxygen therapy, with 30 prescribing it for acute relief and 17 for patients with borderline hypoxemia. Conclusions: This study identified the prescription pattern of home oxygen therapy in Korea. Respiratory physicians prescribe home oxygen therapy to hypoxemic COPD patients for at least 15 hours/day, and at a rate of less than 2 L/ min. More research is needed to provide evidence for establishing policies on oxygen therapy in COPD patients.

플라즈마 및 직접 기상 불소화에 따른 활성탄소섬유의 초산가스 흡착 특성

이란은 ( Raneun Lee ),임채훈 ( Chaehun Lim ),김민지 ( Min-ji Kim ),이영석 ( Young-seak Lee ) 한국공업화학회 2021 공업화학 Vol.32 No.1

실내 환경 오염물질인 휘발성 유기화합물(volatile organic compounds)인 초산에 대한 핏치계 활성탄소섬유의 흡착 성능을 향상시키기 위해 불소화를 진행하였다. 불소화에는 플라즈마 불소화와 직접 기상 불소화법을 사용하였으며, 두 가지 방식으로 불소화한 활성탄소섬유의 초산가스 흡착 성능을 고찰하였다. 불소가 도입된 활성탄소섬유의 표면 특성을 알아보기 위하여 X선 광전자 분광법(XPS)을 분석하였고 그 기공특성은 77K 질소 흡착법을 통하여 분석하였다. 초산가스의 흡착 성능은 가스 크로마토그래피를 통하여 측정하였으며, 플라즈마 불소화 된 활성탄소섬유의 파과시간이 790 min으로 650 min인 미처리 활성탄소섬유에 비해 파과시간이 지연되었음을 확인할 수 있으나, 직접 기상 불소화 표면처리한 활성탄소섬유의 파과시간은 390 min으로 오히려 흡착성능이 저해되었다. 이는 플라즈마 불소화 된 활성탄소섬유는 그 비표면적의 변화 없이, 표면에 도입된 불소 관능기가 초산가스(CH₃COOH)와 정전기적 인력으로 흡착성능이 증가하였다. 반면, 직접 기상 불소화 된 활성탄소섬유는 그 비표면적이 55%까지 크게 감소하여 초산가스에 대한 물리적 흡착 효과가 현저히 감소하였다. Fluorination was carried out to improve the adsorption performance of pitch-based activated carbon fibers (ACFs) onto acetic acid. Both plasma and direct gas fluorination were used for fluorination, and the acetic acid gas adsorption performance of fluorinated ACFs was investigated. X-ray photoelectron spectroscopy (XPS) is analyzed to determine the surface characteristics of ACFs, and the pore characteristics were analyzed by 77 K nitrogen adsorption. An adsorption performance was measured through gas chromatography, and it was confirmed that the breakthrough time of plasma fluorinated sample was 790 min and that the breakthrough time was delayed compared to that of using untreated one of 650 min. However, the breakthrough time of direct gas fluorinated sample was 390 min, indicating that the adsorption performance was inhibited. The plasma fluorinated ACFs showed an increase in the adsorption performance due to an electrostatic attraction between the acetic acid gas (CH₃COOH) with the fluorine group introduced to the surface without changing its specific surface area. On the other hand, the specific surface area of the direct gas fluorinated ACFs decreased significantly up to 55%, and the physical adsorption effect on the acetic acid gas also reduced.